234 related articles for article (PubMed ID: 23061466)
1. Human ether-a-go-go-related gene channel blockers and its structural analysis for drug design.
Narayana Moorthy NS; Ramos MJ; Fernandes PA
Curr Drug Targets; 2013 Jan; 14(1):102-13. PubMed ID: 23061466
[TBL] [Abstract][Full Text] [Related]
2. Analysis of van der Waals surface area properties for human ether-a-go-go-related gene blocking activity: computational study on structurally diverse compounds.
Moorthy NS; Ramos MJ; Fernandes PA
SAR QSAR Environ Res; 2012 Jul; 23(5-6):521-36. PubMed ID: 22452318
[TBL] [Abstract][Full Text] [Related]
3. The effects of a novel anti-arrhythmic drug, acehytisine hydrochloride, on the human ether-a-go-go related gene K channel and its trafficking.
Huang X; Yang Y; Zhu J; Dai Y; Pu J
Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):145-54. PubMed ID: 19143746
[TBL] [Abstract][Full Text] [Related]
4. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of liensinine and neferine on the human ether-a-go-go-related gene potassium channel and pharmacological activity analysis.
Dong ZX; Zhao X; Gu DF; Shi YQ; Zhang J; Hu XX; Hu MQ; Yang BF; Li BX
Cell Physiol Biochem; 2012; 29(3-4):431-42. PubMed ID: 22508050
[TBL] [Abstract][Full Text] [Related]
6. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current.
Inanobe A; Kamiya N; Murakami S; Fukunishi Y; Nakamura H; Kurachi Y
J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of sophocarpine and sophoridine on hERG K+ channel.
Zhao XL; Gu DF; Qi ZP; Chen MH; Wei T; Li BX; Yang BF
Eur J Pharmacol; 2009 Apr; 607(1-3):15-22. PubMed ID: 19224706
[TBL] [Abstract][Full Text] [Related]
8. Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers.
Aronov AM
J Med Chem; 2006 Nov; 49(23):6917-21. PubMed ID: 17154521
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical determinants for drug induced blockade of HERG potassium channels: effect of charge and charge shielding.
Zolotoy AB; Plouvier BP; Beatch GB; Hayes ES; Wall RA; Walker MJ
Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):225-41. PubMed ID: 15326914
[TBL] [Abstract][Full Text] [Related]
10. [HERG K+ channel, the target of anti-arrhythmias drugs].
Guan FY; Yang SJ
Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
[TBL] [Abstract][Full Text] [Related]
11. The hERG potassium channel as a therapeutic target.
Witchel HJ
Expert Opin Ther Targets; 2007 Mar; 11(3):321-36. PubMed ID: 17298291
[TBL] [Abstract][Full Text] [Related]
12. Effect of daurisoline on HERG channel electrophysiological function and protein expression.
Liu Q; Mao X; Zeng F; Jin S; Yang X
J Nat Prod; 2012 Sep; 75(9):1539-45. PubMed ID: 22974355
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of pentamidine-affected ion channel trafficking and dofetilide mediated rescue.
Varkevisser R; Houtman MJ; Linder T; de Git KC; Beekman HD; Tidwell RR; Ijzerman AP; Stary-Weinzinger A; Vos MA; van der Heyden MA
Br J Pharmacol; 2013 Jul; 169(6):1322-34. PubMed ID: 23586323
[TBL] [Abstract][Full Text] [Related]
14. A critical assessment of combined ligand- and structure-based approaches to HERG channel blocker modeling.
Du-Cuny L; Chen L; Zhang S
J Chem Inf Model; 2011 Nov; 51(11):2948-60. PubMed ID: 21902220
[TBL] [Abstract][Full Text] [Related]
15. Papaverine, a vasodilator, blocks the pore of the HERG channel at submicromolar concentration.
Kim YJ; Hong HK; Lee HS; Moh SH; Park JC; Jo SH; Choe H
J Cardiovasc Pharmacol; 2008 Dec; 52(6):485-93. PubMed ID: 19034039
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of Guanfu base A and Guanfu base G on HERG K+ channel.
Huang X; Yang Y; Zhu J; Xu D; Peng J; Liu J
J Cardiovasc Pharmacol; 2012 Jan; 59(1):77-83. PubMed ID: 21934630
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a compound that protects cardiac tissue from human Ether-à-go-go-related gene (hERG)-related drug-induced arrhythmias.
Potet F; Lorinc AN; Chaigne S; Hopkins CR; Venkataraman R; Stepanovic SZ; Lewis LM; Days E; Sidorov VY; Engers DW; Zou B; Afshartous D; George AL; Campbell CM; Balser JR; Li M; Baudenbacher FJ; Lindsley CW; Weaver CD; Kupershmidt S
J Biol Chem; 2012 Nov; 287(47):39613-25. PubMed ID: 23033485
[TBL] [Abstract][Full Text] [Related]
18. Predictive QSAR models development and validation for human ether-a-go-go related gene (hERG) blockers using newer tools.
Moorthy NS; Ramos MJ; Fernandes PA
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):317-24. PubMed ID: 23560722
[TBL] [Abstract][Full Text] [Related]
19. Blockade of HERG K+ channel by isoquinoline alkaloid neferine in the stable transfected HEK293 cells.
Gu DF; Li XL; Qi ZP; Shi SS; Hu MQ; Liu DM; She CB; Lv YJ; Li BX; Yang BF
Naunyn Schmiedebergs Arch Pharmacol; 2009 Aug; 380(2):143-51. PubMed ID: 19424681
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
Guo J; Gang H; Zhang S
J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]